|
Robert P. Lanza, M.D., serves as Senior Director of Tissue Engineering and Transplant Medicine at Advanced Cell Technology, Inc. and Vice President of Business Development at ACT Group, Inc. Dr. Lanza is a former Fulbright Scholar and has been nominated for a MacArthur Foundation "genius" award. He has published more than 200 papers, abstracts, and books, including Principles of Tissue Engineering (2nd ed., coedited with Robert Langer and Joseph Vacanti; San Diego, CA: Academic Press, 2000); Yearbook of Cell and Tissue Transplantation 1996/1997 (coedited with William L. Chick; Boston: Kluwer Academic Publishers, 1996); and One World: The Health and Survival of the Human Species in the 21st Century (as editor, with Forewords by C. Everett Koop and former President Jimmy Carter; Santa Fe, NM: Health Press, 1996). His forthcoming book (coauthored with DKC Cooper) is XENO: The Promise of Transplanting Animal Organs Into Humans (Oxford University Press), due in bookstores in March. Dr. Lanza received his B.A. and M.D. degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar. As a student, he studied with medical pioneers Jonas Salk and Christiaan Barnard and with Nobel laureates Gerald Edelman and Rodney Porter. Dr. Lanza's current area of research focuses on the use of nuclear transfer and stem cells in human transplantation.. |